Up to 40% of ER-positive breast cancers have a PIK3CA mutation and are associated with poor prognosis; this approval helps address an urgent unmet need2-4 Itovebi is the first PI3K-targeted therapy to ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

In a significant advancement for prostate cancer research, a first-of-its kind study led by Emory researchers uncovered how ...

Faith in the possibility of 'enhancing' humankind – the extension human abilities and lifespan by any technological means – ...

In a significant advancement for prostate cancer research, a first-of-its kind study led by Emory researchers uncovered how the disease transforms ...

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

When guys reach 30 years old, they enter a period known as “somatopause,” where human growth hormone levels start to drop profoundly. But, thankfully, you've got options. There's a way to take ...

Note that some links may require registration or subscription. The HHS Office for Civil Rights launched an investigation into ...

DelveInsight's Diabetes pipeline report depicts a robust space with 200+ active players working to develop 200+ pipeline ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...